These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1416 related items for PubMed ID: 8428361

  • 1. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W, Chaney SG.
    Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361
    [Abstract] [Full Text] [Related]

  • 2. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
    Kido Y, Khokhar AR, al-Baker S, Siddik ZH.
    Cancer Res; 1993 Oct 01; 53(19):4567-72. PubMed ID: 8402629
    [Abstract] [Full Text] [Related]

  • 3. Role of carrier ligand in platinum resistance in L1210 cells.
    Gibbons GR, Page JD, Mauldin SK, Husain I, Chaney SG.
    Cancer Res; 1990 Oct 15; 50(20):6497-501. PubMed ID: 2208108
    [Abstract] [Full Text] [Related]

  • 4. Mechanism-related circumvention of acquired cis-diamminedichloroplatinum(II) resistance using two pairs of human ovarian carcinoma cell lines by ammine/amine platinum(IV) dicarboxylates.
    Kelland LR, Mistry P, Abel G, Loh SY, O'Neill CF, Murrer BA, Harrap KR.
    Cancer Res; 1992 Jul 15; 52(14):3857-64. PubMed ID: 1617660
    [Abstract] [Full Text] [Related]

  • 5. Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.
    Mamenta EL, Poma EE, Kaufmann WK, Delmastro DA, Grady HL, Chaney SG.
    Cancer Res; 1994 Jul 01; 54(13):3500-5. PubMed ID: 8012973
    [Abstract] [Full Text] [Related]

  • 6. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.
    Yoshida M, Khokhar AR, Siddik ZH.
    Cancer Res; 1994 Jul 01; 54(13):3468-73. PubMed ID: 8012968
    [Abstract] [Full Text] [Related]

  • 7. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
    Han I, Ling YH, al-Baker S, Khokhar AR, Perez-Soler R.
    Cancer Res; 1993 Oct 15; 53(20):4913-9. PubMed ID: 8402681
    [Abstract] [Full Text] [Related]

  • 8. Transport of cisplatin and bis-acetato-ammine-dichlorocyclohexylamine Platinum(IV) (JM216) in human ovarian carcinoma cell lines: identification of a plasma membrane protein associated with cisplatin resistance.
    Sharp SY, Rogers PM, Kelland LR.
    Clin Cancer Res; 1995 Sep 15; 1(9):981-9. PubMed ID: 9816070
    [Abstract] [Full Text] [Related]

  • 9. Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
    Yoshida M, Khokhar AR, Siddik ZH.
    Cancer Res; 1994 Sep 01; 54(17):4691-7. PubMed ID: 8062266
    [Abstract] [Full Text] [Related]

  • 10. Comparison of cellular accumulation and cytotoxicity of cisplatin with that of tetraplatin and amminedibutyratodichloro(cyclohexylamine)platinum(IV) (JM221) in human ovarian carcinoma cell lines.
    Mistry P, Kelland LR, Loh SY, Abel G, Murrer BA, Harrap KR.
    Cancer Res; 1992 Nov 15; 52(22):6188-93. PubMed ID: 1423261
    [Abstract] [Full Text] [Related]

  • 11. Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum(II).
    Masuda H, Tanaka T, Matsuda H, Kusaba I.
    Cancer Res; 1990 Mar 15; 50(6):1863-6. PubMed ID: 2306738
    [Abstract] [Full Text] [Related]

  • 12. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF, Koberle B, Masters JR, Kelland LR.
    Br J Cancer; 1999 Dec 15; 81(8):1294-303. PubMed ID: 10604725
    [Abstract] [Full Text] [Related]

  • 13. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J, Liebeke M, Kaiser M, Bracht K, Olszewski U, Zeillinger R, Hamilton G, Braun D, Bednarski PJ.
    Anticancer Drugs; 2009 Aug 15; 20(7):559-72. PubMed ID: 19491657
    [Abstract] [Full Text] [Related]

  • 14. Ormaplatin sensitivity/resistance in human ovarian cancer cells made resistant to cisplatin.
    Parker RJ, Vionnet JA, Bostick-Bruton F, Reed E.
    Cancer Res; 1993 Jan 15; 53(2):242-7. PubMed ID: 8417816
    [Abstract] [Full Text] [Related]

  • 15. Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.
    Behrens BC, Hamilton TC, Masuda H, Grotzinger KR, Whang-Peng J, Louie KG, Knutsen T, McKoy WM, Young RC, Ozols RF.
    Cancer Res; 1987 Jan 15; 47(2):414-8. PubMed ID: 3539322
    [Abstract] [Full Text] [Related]

  • 16. Establishment and characterization of an in vitro model of acquired resistance to cisplatin in a human testicular nonseminomatous germ cell line.
    Kelland LR, Mistry P, Abel G, Freidlos F, Loh SY, Roberts JJ, Harrap KR.
    Cancer Res; 1992 Apr 01; 52(7):1710-6. PubMed ID: 1312897
    [Abstract] [Full Text] [Related]

  • 17. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.
    Shellard SA, Hosking LK, Hill BT.
    Cancer Res; 1991 Sep 01; 51(17):4557-64. PubMed ID: 1873800
    [Abstract] [Full Text] [Related]

  • 18. In vitro studies on the mechanisms of oxaliplatin resistance.
    Hector S, Bolanowska-Higdon W, Zdanowicz J, Hitt S, Pendyala L.
    Cancer Chemother Pharmacol; 2001 Nov 01; 48(5):398-406. PubMed ID: 11761458
    [Abstract] [Full Text] [Related]

  • 19. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
    Tanaka T, Masuda H, Naito M, Tamai H.
    Anticancer Res; 2001 Nov 01; 21(4A):2463-9. PubMed ID: 11724308
    [Abstract] [Full Text] [Related]

  • 20. Modulation of the cellular pharmacology of JM118, the major metabolite of satraplatin, by copper influx and efflux transporters.
    Samimi G, Howell SB.
    Cancer Chemother Pharmacol; 2006 Jun 01; 57(6):781-8. PubMed ID: 16170571
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 71.